Celsion Corporation (NASDAQ:CLSN)

CAPS Rating: 1 out of 5

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.

Recs

0
Player Avatar pchop123 (79.52) Submitted: 11/12/2012 5:04:51 PM : Outperform Start Price: $22.95 CLSN Score: +17.78

Bottoming out right now with more upside on the way

Featured Broker Partners


Advertisement